drugset / Trial / NCT03391882

A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

NCT03391882

Phase 3 Completed 113 enrolled Sumitomo Pharma America, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A study of an investigational drug to see how it affects the people with Parkinson's Disease complicated by motor fluctuations ("OFF" Episodes) compared to an approved drug used to treat people with Parkinson's Disease complicated by motor fluctuations ("OFF" Episodes)

Timeline

Start
2018-12-19
Primary completion
2021-08-11
Completion
2021-08-11

Drugs

EvaluationDrugModalityDoseRoute
Subject APL-130277 Unknown Other
Comparator Apomorphine Unknown Subcutaneous

Indications